Curaleaf and Trulieve Dominate the 2026 Cannabis AI Visibility Index Rankings

The latest Cannabis AI Visibility Index for 2026, released by the AI Communications Firm 5W, indicates a significant shift in the ranking of top cannabis brands in the U.S. Curaleaf and Trulieve, two notable multi-state operators (MSOs), have emerged as frontrunners, claiming an impressive combined share of 17.5% of all cannabis-related AI citations. This represents a pivotal moment in the industry, coinciding with a landmark executive order that has rescheduled cannabis to Schedule III, thus changing how the market operates.

A New Era for Cannabis

The rescheduling of cannabis products follows a directive from former President Trump on December 18, 2025, and has been officially enacted by the DOJ and DEA. This regulatory change places both FDA-approved marijuana products and state-licensed medical marijuana under the new designation. Experts in the field note that this rescheduling marks the most significant citation adjustment since cannabis legalization began, setting the stage for unprecedented growth and shifts in consumer behavior.

According to 5W’s findings, when over 50 consumer prompts were analyzed through various AI platforms, it was revealed that Curaleaf commanded approximately 7.5% of the total AI citations, while Trulieve followed closely with 6.5%. The brand Cookies leads the category for branded consumer cannabis products with a substantial margin. Charlotte's Web continues to hold the title for the top CBD brand for an impressive five consecutive years.

The Citations Landscape

The AI Visibility Index categorizes brands into five segments: U.S. multi-state operators, branded cannabis consumer products, CBD-specific brands, dispensary aggregators, and ancillary services. The results show that Leafly and Weedmaps are notable players in the aggregator space, outpacing every individual MSO except for Curaleaf. Notably, these three brands' combined participation showcases how MSOs can leverage technology to enhance their visibility amidst rapidly evolving regulations.

However, the data also highlights challenges within the industry. Approximately 28% of the cannabis prompts analyzed resulted in AI engine refusals or disclaimers, starkly higher compared to any other consumer category. This phenomenon illustrates the difficulties of navigating the complexities surrounding cannabis legality and safety, as well as the importance of credibility in building brand reputation.

Preparing for Federal Clarity

Industry experts like Ronn Torossian, the founder of 5W, have pointed to the fragmentation of cannabis laws across the U.S. as a contributing factor to the volatility in AI citations. Brands proficient at creating content addressing topics like state-specific legality, medical applications, and dosage information are positioned to gain more visibility. Those brands that hesitate to adapt to these changes are likely to lose ground to competitors who have forged ahead with proactive strategies.

“With 28% of prompts yielding hedges or refusals, the necessity for cannabis brands to articulate clarity and comply with state laws is essential,” Torossian stated. “Brands that proactively develop educational content will command greater citation share and consumer trust in the long run.”

Conclusion

As the landscape changes rapidly, the implications of the 2026 Cannabis AI Visibility Index extend well beyond rankings. The report emphasizes the need for brands to stay agile, responsive, and informed about regulatory shifts. For operators within this burgeoning sector, the opportunity for expansion is ripe, but it comes paired with the challenge of establishing a reliable and solid brand presence in an environment marked by uncertainties and continuous transformation. The full findings, which include comprehensive rankings and methodologies, are accessible on 5W’s website, reiterating their commitment to providing insights that shape the future of cannabis branding.